Veracyte, Inc. share price logo

Veracyte, Inc. Share Price

NASDAQ: VCYT

Mid Cap

$38.71

+0.23

(+0.60%)

as on

Veracyte, Inc. Stock Performance

as on January 30, 2026 at 2:29 am IST

  • Day's Low

    Day's High

    $37.81
    $38.73
    downward going graph

    2.32%

    Downside

    0.05%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $22.61
    $50.71
    downward going graph

    41.59%

    Downside

    31.00%

    Upside

    downward going graph

Veracyte, Inc. share price movements today

Previous Close
$38.48
Open
$38.15
Volume
451.9K
Day's Low - High
$37.81 - $38.73
52 Week Low - High
$22.61 - $50.71

Veracyte, Inc. Historical Returns

1 Month Return
-8.37 %
3 Month Return
+ 9.65 %
1 Year Return
-16.04 %
3 Year Return
+ 57.93 %
5 Year Return
-31.68 %

Veracyte, Inc. Stock Fundamentals & Key Indicators

Check Veracyte, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.1B

EPS (TTM)

1.6602

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.26%

PE Ratio (TTM)

107.57

Industry PE ratio

5.33235294117647

PEG Ratio

0

EBITDA

73.7M

Revenue (TTM)

495.1M

Profit Margin

6.12%

Return On Equity TTM

2.49%

Veracyte, Inc. Stock Valuation

Track how Veracyte, Inc. P/E has moved over time to understand its valuation trends.

Veracyte, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-187.55x)

September 30, 2024

Industry (5.33x)

January 30, 2026

Today (107.57x)

January 30, 2026

Highest (63.11x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 107.57x

Veracyte, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Veracyte, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Veracyte, Inc. image
Veracyte, Inc.
BUY$3.1B-31.68%107.576.12%
Idexx Laboratories, Inc. image
Idexx Laboratories, Inc.
BUY$55.8B41.37%55.2524.65%
Thermo Fisher Scientific, Inc. image
Thermo Fisher Scientific, Inc.
BUY$235.4B16.18%36.2415.02%
Iqvia Holdings Inc. image
Iqvia Holdings Inc.
BUY$41.0B32.52%33.118.07%
Agilent Technologies Inc. image
Agilent Technologies Inc.
BUY$38.5B10.9%29.7518.75%
See all

Stock Returns calculator for Veracyte, Inc. Stock including INR - Dollar returns

The Veracyte, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Veracyte, Inc. investment value today

Current value as on today

₹90,009

Returns

₹9,991

(-9.99%)

Returns from Veracyte, Inc. Stock

₹16,103 (-16.1%)

Dollar Returns*

₹6,113 (+6.11%)

Analyst Recommendation on Veracyte, Inc. Stock

Based on 15 analysts

BUY

73.33%

Buy

20.00%

Hold

6.67%

Sell

Based on 15 analysts, 73.33% of analysts recommend a 'BUY' rating for Veracyte, Inc.. Average target price of $47.67

Veracyte, Inc. Share Price Target

Get share price movements and forecasts by analysts on Veracyte, Inc..

What analysts predicted

18.8%UPSIDE

Target Price

$47.67

Current Price

$38.71

Analyzed by

15 Analysts

Target

$47.67

Veracyte, Inc. target price $47.67, a slight upside of 18.8% compared to current price of $38.71. According to 15 analysts rating.

Veracyte, Inc. Stock’s Investor Sentiment and Interest

Search interest for Veracyte, Inc. Stock has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-13% versus previous 30 day period

Veracyte, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
90
90
98
96
114
115
118
114
130
131
Gross Profit
55
62
68
62
77
79
78
79
89
91
Operating Income
-8
-31
-35
-4
4
12
4
2
-5
22
EBITDA
-1
-22
-24
1
13
22
9
6
6
24
Interest Expense
0
0
0
-
0
0
-
-
-
-
Depreciation
6
7
6
5
5
5
6
5
5
5
Income Before Tax
-8
-29
-30
-1
7
16
3
7
1
18
Income Tax Expense
0
0
-2
0
1
1
-1
0
2
0
Net Income
-8
-29
-28
-1
5
15
5
7
0
19
Net Profit Margin
-9.30%
-32.87%
-28.81%
-1.92%
5.01%
13.08%
4.31%
6.16%
-0.75%
14.51%

Veracyte, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
49
65
71
92
120
117
219
296
361
445
Gross Profit
28
39
43
58
83
76
145
194
248
298
Operating Income
-33
-28
-26
-22
-15
-35
-81
-41
-85
16
EBITDA
-32
-25
-23
-17
-7
-26
-60
-6
-49
49
Interest Expense
0
2
4
1
0
0
0
0
0
0
Depreciation
-
-
3
3
4
7
19
25
27
23
Income Before Tax
-33
-31
-31
-22
-12
-34
-81
-36
-76
25
Income Tax Expense
0
2
5
1
3
0
-6
0
-2
1
Net Income
-33
-31
-31
-22
-12
-34
-75
-36
-74
24
Net Profit Margin
-68.08%
-48.18%
-43.09%
-25.00%
-10.47%
-29.71%
-34.42%
-12.33%
-20.61%
5.41%

Veracyte, Inc. Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-29
-28
-1
5
15
5
7
0
19
Operating Cash Flow
14
15
-8
29
29
24
5
33
44
Investing Cash Flow
-2
-2
2
-2
-2
-54
-51
0
48
Financing Cash Flow
0
0
0
0
10
-4
-6
0
2
Change in Cash
11
13
-7
26
38
-34
-52
33
96

Veracyte, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-31
-31
-22
-12
-34
-75
-36
-74
24
Operating Cash Flow
-27
-23
-13
-3
-9
-31
7
44
75
Investing Cash Flow
-4
-1
-1
-42
-3
-739
-29
15
-56
Financing Cash Flow
52
0
59
127
203
596
3
2
4
Change in Cash
20
-25
44
81
190
-176
-18
62
23

Global Institutional Holdings in Veracyte, Inc.

Funds
Holdings
Sumitomo Mitsui Trust Group Inc
2.09%
First Trust Advisors L.P.
1.36%
Qube Research & Technologies
1.25%
Bank of America Corp
1.93%
Artisan Partners Limited Partnership
8.04%
See all

Veracyte, Inc. News & Key Events

    Insights on Veracyte, Inc.

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, VCYT has outperformed top 5 stocks with highest market-cap in its industry

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 3 quarters, 114.47M → 131.87M (in $), with an average increase of 6.7% per quarter

    • imgPOSITIVE IMPACT

      Profit Spike

      img

      Netprofit is up for the last 2 quarters, -980.0K → 19.13M (in $), with an average increase of 105.1% per quarter

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Idexx Laboratories, Inc. has given 62.2% return, outperforming this stock by 78.8%

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 7 days, VCYT stock has moved down by -9.0%

    About Veracyte, Inc.

    veracyte is a pioneering genomic diagnostics company. our tests are dramatically improving clinical outcomes for patients by resolving inconclusive results from traditional diagnostic methods. we ask the right questions to resolve ambiguity and bring assurance to light, rendering tens of thousands of costly and unnecessary surgeries truly unnecessary. we are giving patients a clearer path forward. through scientific rigor we employ the best tools, best science and best minds to create tests that enable a more accurate diagnosis without the need for risky, costly and often unnecessary surgery. veracyte consistently brings to bear evidence that is unprecedented in genomic tests, thereby changing today's clinical practice standards. we are making a difference in the lives of physicians and patients. we are doing something real. .
    OrganisationVeracyte, Inc.
    Headquarters6000 Shoreline Court, South San Francisco, CA, United States, 94080
    IndustryHealth Technology
    CEOMr. Marc A. Stapley
    E-voting on sharesClick here to vote

    Key Management of Veracyte, Inc.

    Name

    Title

    Mr. Jonathan Wygant

    VP & Chief Accounting Officer

    Mr. Steven French

    Senior VP & Chief Information Officer

    Ms. Corinne Danan

    Senior Vice President

    Mr. Marc A. Stapley

    CEO & Director

    Ms. Annie McGuire

    Executive VP, General Counsel & Chief People Officer

    Dr. John Leite Ph.D.

    Global Chief Commercial Officer

    Dr. Keith Gligorich Ph.D.

    Senior Vice President of Global Operations

    Ms. Karen Possemato

    Senior Vice President of Corporate Marketing, Communications & Commercial Operations

    Ms. Rebecca Chambers

    Executive VP & CFO

    Dr. Phillip G. Febbo M.D.

    Chief Scientific & Medical Officer

    FAQs

    What is Veracyte, Inc. share price today?

    Veracyte, Inc. share price today is $38.71 as on at the close of the market. Veracyte, Inc. share today touched a day high of $38.73 and a low of $37.81.

    What is the 52 week high and 52 week low for Veracyte, Inc. share?

    Veracyte, Inc. share touched a 52 week high of $50.71 on and a 52 week low of $22.61 on . Veracyte, Inc. stock price today i.e. is closed at $38.71,which is 23.66% down from its 52 week high and 71.21% up from its 52 week low.

    What is Veracyte, Inc.'s market capitalisation today?

    Veracyte, Inc. market capitalisation is $0.00T as on .

    How to invest in Veracyte, Inc. Stock (VCYT) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Veracyte, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Veracyte, Inc. Shares that will get you 0.0387 shares as per Veracyte, Inc. share price of $38.71 per share as on January 30, 2026 at 2:29 am IST.

    What is the minimum amount required to buy Veracyte, Inc. Stock (VCYT) from India?

    Indian investors can start investing in Veracyte, Inc. (VCYT) shares with as little as ₹91.936 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹919.36 in Veracyte, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Veracyte, Inc. share’s latest price of $38.71 as on January 30, 2026 at 2:29 am IST, you will get 0.2583 shares of Veracyte, Inc.. Learn more about fractional shares .

    What are the returns that Veracyte, Inc. has given to Indian investors in the last 5 years?

    Veracyte, Inc. stock has given -31.68% share price returns and 25.8% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?